Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer
Yao Sun, Zhenzhen Yin, Shuang Li, Limeng Wu, Yanling Zhang, Yanxia Zhao, Igor L Gomes dos Santos, Sonu Subudhi, Pin‐Ji Lei, Alona Muzikansky, Zhiyong Yuan, Bo R. Rueda, Rakesh K. Jain, Lei Xu
Topics & Concepts
ImmunotherapyImmune systemTumor microenvironmentCancer researchMedicineLosartanOvarian cancerCancerEverolimusInternal medicineImmunologyOncologyReceptorAngiotensin IIAngiogenesis and VEGF in CancerOvarian cancer diagnosis and treatmentCancer Cells and Metastasis